Environmental conditioning in the control of macrophage thrombospondin-1 production by Fordham, Jezrom B. et al.
 
Environmental conditioning in the control of macrophage
thrombospondin-1 production
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Fordham, Jezrom B., Jing Hua, Sarah R. Morwood, Lauren P.
Schewitz-Bowers, David A. Copland, Andrew D. Dick, and
Lindsay B. Nicholson. 2012. Environmental conditioning in the
control of macrophage thrombospondin-1 production. Scientific
Reports 2:512.
Published Version doi:10.1038/srep00512
Accessed February 19, 2015 10:48:12 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10464971
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAAEnvironmental conditioning in the control
of macrophage thrombospondin-1
production
Jezrom B. Fordham
1, Jing Hua
1*, Sarah R. Morwood
1, Lauren P. Schewitz-Bowers
1, David A. Copland
1,
Andrew D. Dick
1,2 & Lindsay B. Nicholson
1,2
1School of Clinical Sciences, University of Bristol, Bristol, UK and,
2School of Cellular and Molecular Medicine, University of Bristol,
Bristol, UK.
Thrombospondin-1 (TSP-1) is a multifunctional protein which is secreted into the extracellular matrix
duringinflammation,whereitmodulatesnumerouscomponentsoftheimmuneinfiltrate.Macrophagesare
a source of TSP-1, which they produce in response to TLR4 mediated signals. Their production of TSP-1 is
regulated by environmental signals that establish a threshold for the level of protein secretion that can be
induced by LPS stimulation. Th1 and Th2 cytokines raise this threshold which leads to less TSP-1
production, while signals that promote the generation of regulatory macrophages lower it. TSP-1 plays no
directroleintheregulationofitsownsecretion.Invivoinuveitis,inthepresenceofTLR-4ligands,TSP-1is
initially produced by recruited macrophages but this decreases in the presence of inflammatory cytokines.
The adaptive immune system therefore plays a dominant role in regulating TSP-1 production in the target
organ during acute inflammation.
M
acrophagesactasabridgebetweeninnateandadaptiveimmunity,byrespondingtosignalsfrompattern
recognition receptors such as Toll-Like Receptors (TLRs) and modulating T helper cell stimulation.
Extracellularcuesdriveawiderangeofdifferentbutoverlappinggeneprogramsthatarecommonlyused
todefinephenotype
1,2.Residentmacrophages,presentinvirtuallyalltissuesofthebody,playasentinelroleinthe
surveillance, compartmentalisation and presentation of pathogens
3. Pathogen-associated danger signals stimu-
late and recruit macrophages, leading to the release of pro-inflammatory molecules, chemo-attractants, and
extracellular matrix-altering molecules that initiate and regulate inflammation and immune infiltrate
4. One
important effector molecule is thrombospondin-1, a protein that plays a role in a number of different organ
specific autoimmune diseases
5,6.
Thrombospondin-1 (TSP-1) is a multifunctional extracellular matrix protein. In adults its expression is
restricted, but at sites of inflammation it modulates several components of the immune response. The effects
of TSP-1 include, but are not limited to, neutrophil and monocyte chemotaxis
7,8, phagocytosis of neutrophils
9,
regulation of Tcell function via receptor ligation
10, activation of latentTGF-b1
11, and the inhibition of angiogen-
esis
12.ThephenotypeoftheTSP-1KOmousehasbeenwelldescribed,presentinginawaythatissimilarto,albeit
less severe than TGF-b1 and TGF-bR KO mice
13. Despite this chronic inflammatory phenotype characterised by
systemic leukocytosis
14, raised levels of pro-inflammatory cytokines and impaired wound healing
15, and a
Sjorgren’s syndrome like ocular surface disease
16 the TSP-1 KO mouse is resistant to some models of autoim-
munity, such as Experimental Autoimmune Encephalomyelitis (EAE)
6, while remaining susceptible to others,
such as Experimental Autoimmune Uveoretinitis (EAU)
5. The phenotype of the T cell response in both these
modelsisthesame(S.R.MorwoodandL.B.Nicholson;unpublisheddata),whichmakesitdifficulttounderstand
how the outcomes of the diseases are divergent. Local factors in the eye may be important to the differences in
outcome because of the critical role of TSP-1 in the regulation of angiogenesis
17, since in chronic uveitis, TSP-1
KO animals develop significantly more retinal angiogenesis than WT controls and this is associated with altera-
tions inthe phenotype ofthe infiltrating macrophages
18.It istherefore important to understand the regulation of
TSP-1 by recruited macrophages, which are the dominant cell population during the early stages of uveitis and
remain present throughout the course of disease.
In this paper we have characterised signals that induce TSP-1 production by macrophages. We demonstrate
that the local environment sets a threshold for TSP-1 production with the highest levels of protein elicited by
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reported role of TSP-1 in tolerance
19. Importantly we further show
that the generation of TSP-1 is inhibited by Th1 and Th2, but not
Th17 cytokines. The rapid down-regulation of TSP-1 production, in
thepresence ofactivated Tcells isconfirmed byinvivoobservations,
using the acute endotoxin induced uveitis model, in which the early
production of TSP-1 in response to TLR4 ligation is reduced as T
cells accumulate at the site of inflammation and by studies of acute
inflammation in EAU.
Results
TLR4 dependent TSP-1 production by BM-MW is inhibited by
Th1 and Th2 cytokines. Under innate inflammatory conditions,
macrophages upregulate the production of TSP-1
20 a response that
canbeinducedbylipopolysaccharide(LPS)
21.Thiscanbedetectedat
the protein level by intracytoplasmic staining of TSP-1. To re-
capitulate this observation in our system, we compared LPS with
other ligands that engage pattern recognition receptors expressed
on BM-MW, to confirm this effect on TSP-1 expression.
Stimulation for 24 hours with, BLP a TLR2 ligand
22 or CpG a
TLR9 ligand did not increase TSP-1 protein production. In
comparison, treatment with the LPS, a TLR4 ligand, increased
expression of TSP-1 approximately 6 fold after 24 hours of
treatment (Fig 1A). When cells were cultured for longer periods,
up to 72 hours, TSP-1 expression was maintained and increased
slightly until approximately 40% of cells produced TSP-1 (data not
shown). To establish the requirement for TLR4 signalling more
precisely, we then tested BM-MW from wild type or TLR4
knockout mice stimulated with LPS or ultrapure LPS and
measured nitrite (NO) or TSP-1 production (Fig 1B). In this assay
TLR4 knockout BM-MW were unable to upregulate TSP-1 in the
presence of LPS.
HavingconfirmedthatLPSstimulatedBM-MWTSP-1production
in a TLR4 dependent fashion, we wished to consider the control of
TSP-1 expression by a more complex inflammatory microenviron-
ment. During an adaptive immune response, activated T cells pro-
ducing effector cytokines are present and central to the disease
process
23. Currently the three best characterised subsets of effector
T cells, namely Th1, Th2 and Th17, are defined respectively by the
productionofIFN-c,IL-4andIL-17cytokines.ToaddresstheTSP-1
response of macrophages encountering innate and cytokine signals
together, we cultured BM-MW with LPS for 24 hours, before adding
differenteffectorTcellcytokinesforafurther24 hours.Theaddition
of Th1 or Th2 cytokines reduced TSP-1 production to that the level
of unstimulated cells. In comparison IL-17 had no effect on TSP
production, but when added in combination with IFN-c, the effect
of IFN-c was dominant and TSP-1 production was suppressed
(Fig. 2).
Environmental regulation of TSP-1 production. The effect of
increasing the concentration of LPS to elicit TSP-1 production
demonstrates a conventional dose response with a maximum of
about 40% of the cells expressing protein. TSP-1 engages many
cell surface ligands
24, therefore we wished to determine whether
this limit was reached because of TSP-1 dependent signals
inhibited neighbouring cells from initiating TSP-1 production. To
test this we stimulated mixed cultures of WT and TSP-1 KO BM-
MW in different ratios, reasoning that if TSP-1 was necessary for
inhibition to occur, then cultures in total numbers of WT BM-MW
were lower would have a higher frequency of TSP-1 production
i.e. more of the WT BM-MW cells would produce TSP-1 in
compensation for the reduced total production in the culture.
Using WT and TSP-1 KO cells that express different CD45 allelic
markers, the individual cell populations and their TSP-1 production
could be distinguished by flow cytometry.
The results from these mixed macrophage cultures demonstrated
thatthelevelofTSP-1productionisapropertyofindividualcellsand
not related to environmental TSP-1 levels (Fig 3). When WT cell
numberisdilutedbyTSP-1KOmacrophages,theoverallproduction
of TSP-1 in the culture reduced to baseline levels, but within the WT
population of macrophages, about 40% of the cells continue to pro-
duce TSP-1. We concluded that TSP-1 in the environment is not
influencing thethresholdatwhich macrophages canproduce TSP-1.
Although the fraction of cells producing TSP-1 is not affected by
the presence of TSP-1 itself, the threshold of the macrophage TSP-1
response to LPS can be modified. External stimuli such as Th1 and
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Figure 1 | TSP-1 expression by BM-MWs is stimulated via TLR4. (A)
BM-MWs were cultured for 24 hrs in media alone or in the presence of
various innate ligands. To control forautofluorescence, TSP-1 production
was always determined by comparison with comparably activated TSP-1
KO cells. LPS, but not BLP or CpG induced TSP-1. Results are
representative of 3 independent experiments. (B) WT and TLR4 KO BM-
MWswereculturedinmediaaloneorstimulatedwithLPSorultrapureLPS
for 24 hr and assayed for NO and TSP-1 production. Results are the
averages of 3 separate experiments. ** p5 ,0.01, Mann-Whitney two-
tailed test.
www.nature.com/scientificreports
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toneal macrophages (P-MW), obtained from normal mice and com-
pared with BM-MW, respond to LPS stimulation by up-regulating
TSP-1 expression in a greater proportion of cells (Fig 4A). Baseline
and stimulated levels of TSP-1 production from P-MW was higher
thanBM-MW,asestimatedbymeasuringfrequencyandmeanfluor-
escenceintensityofTSP-1stainingofcells(Fig4B).Thereforefactors
that are independent of the level of TSP-1 protein regulate its pro-
duction.
First we investigated whether the different frequencies of TSP-1
production by BM-MW versus P-MW were intrinsic to cells obtained
from these different environments, or alternatively could be modi-
fied by environmental cues, WT BM-MW and TSP-1 KO P-MW or
BM-MW were then combined and stimulated as mixed cultures with
LPS. TSP-1 production was measured in the WT macrophage popu-
lation. The results demonstrate that approximately 28% of the WT
BM-MW produced TSP-1 when they were co-cultured with TSP-1
KO BM-MW, but when WT BM-MW were cultured with TSP-1 KO
P-MW, the fraction of TSP-1 producing cells increased 2-fold
(Fig 4C). We conclude that macrophages obtained from the periton-
eum can interact with WT BM-MWand rapidly modify their thresh-
old for TSP-1 secretion by in response to LPS stimulation.
It is well recognised that macrophages respond to a wide array of
exogenous signals, and a number of different stimuli have been
described that modify macrophage activation
25. For example, the
ability of different signals to switch macrophages from a classically
activated to a regulatory phenotype, has been intensively investi-
gated
26. In these experiments, it is often an innate signal in combina-
tion with a number of different second signals that alters the
production of effector molecules, particularly IL-10. Because this
response has been carefully documented we wished to investigate
how the production of TSP-1 related to this paradigm. Because we
have found that P-MW but not BM-MW include a population of cells
competent to induce adenosine (JBF and LBN unpublished data) we
tested the role of this mediator. In these experiments and congruent
with this two stage signal model, the addition of adenosine or the
selectiveA2AadenosinereceptoragonistCGS,didnotstimulateTSP-
1 when administered alone, but when added in combination with
LPS they enhanced TSP-1 production from BM-MW (Fig. 5A). The
addition PGE2 could also potentiate TSP-1 production by LPS sti-
mulated macrophages (Fig 5B) an effect that could be inhibited by
indomethacin (data not shown). To assess the role of IL-10 in this
process, we performed parallel experiments using WT and IL-10-
deficient BM-MW. The absence of IL-10 had no impact on the
enhanced TSP-1 production, indicating that this was not an IL-10
dependent response (Fig. 5B). We also considered the impact of
TNFa signalling. LPS induces TNFa that signals through TNFR1
27,
and we therefore tested the production of TSP-1 following LPS
stimulationofTNFR1KOBM-MW.Therewasnodeficitintheability
of these cells to produce TSP-1 in response LPS (Fig. 5C)
It was then important to determine whether enhanced TSP-1
production was susceptible to inhibition by Th1 and Th2 cytokines.
This addresses the outcome of a balance of signal in an adaptive
versus an innate response. The addition of either IFN-c or IL-4
resulted in reduced TSP-1 production by LPS1CGS stimulated
BM-MW (Fig 5D). These experiments show that Th1 and Th2 cyto-
kinesmodulatethethresholdforTSP-1productionbutIL-10andIL-
17 do not. We therefore then studied the impact of this regulation in
the context of inflammation in vivo.
TSP-1 production in vivo. Inflammation precipitated by autoim-
mune disease involves the close collaboration of many cell types,
including macrophages and T cells, that interact to establish a
microenvironment that determines the fate of the organ in
response to the pathological insult
28. Investigating the source of
TSP-1 mRNA up-regulation we found that this segregated to the
macrophage compartment and not to T cells (Fig. 6A). This result
is in conflict with data derived in human T cells, which are reported
to produce TSP-1
29,30. We therefore addressed whether murine naive
or effector T cells produce TSP-1 directly, using TCR transgenic T
cells from OT-II mice, either immediately ex vivo (‘naive’) or
differentiated to a Th1 or Th17 phenotype. When these cells were
stimulated, either with an optimal concentration of anti-CD3 plus
anti-CD28 (Fig 6B) or PMA Ionomycin (data not shown) and
compared with TSP-1 KO T cells, they did not produce detectable
levels of TSP-1 protein. We also examined in vitro generated
dendritic cells (DCs), comparing the production of TSP-1 by
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Figure 3 | TSP-1 secretion is independent of the response of
neighbouring cells. WT and TSP-1 KO BM-MW’s were cultured together
at different ratios andstimulated withLPS for 48 hrs.Expression ofTSP-1
byWT(CD45.1positive)cellswasindependentoftheproportionofTSP-1
KO cells present. Results are the averages for two independent
experiments. TSP-1 gates are based on the positivity of TSP-1 KO cells
being less than 1%.
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Figure 2 | Effect of IFN-c, IL-4 and IL-17 cytokines on BM-MW TSP-1
expression. WTBM-MWswerestimulatedwithLPSfor24 hrsfollowedby
the addition of IFN-c, IL-4, IL-17, or IFN-c combined with IL-17 for a
further 24 hrs. Cells stimulated with LPS alone for 48 hrs were used as
controls. IFN-c and IL-4 inhibited TSP-1 expression while IL-17 had no
effect. Results are the averages from two independent experiments. Plots
were gated on live F4/80
1 cells. * p5,0.05 Mann-Whitney U test.
www.nature.com/scientificreports
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that only the BM-MW upregulated their production of TSP-1
(Fig 6C). This raised the important question of under what
circumstances would the balance of inflammatory signals lead in
vivo inflammatory macrophages to produce TSP-1. To study this
in ocular inflammation, we first assessed the retinas of young
unimmunised TSP-1 KO mice and found that they were broadly
normal, both clinically and histologically. There was no significant
difference in apoptosis in the retina between WT and TSP-1 KO
animals, as assessed by counting cleaved Caspase-3 positive cells in
TSP-1 KO mice and their age matched controls up to 2 years of age.
The only deficit we identified in non-manipulated TSP-1 KO mice
was a slight thinning of nuclear layers at 2 years of age, (Fig 6D).
To investigate the response to inflammation we then studied two
models of uveitis. Endotoxin-induced uveitis (EIU), which results
from by the injection of LPS
31,32 provides a strong TLR-4 dependent
signal in the local tissue. It produces an acute disease of about seven
days duration, which is accompanied by a breakdown in the blood-
retinal and blood-aqueous barriers and an influx of inflammatory
leukocytes. Experimental autoimmune uveoretinitis (EAU) is a pro-
totypical autoimmune disease that produces a pathogenic adaptive
autoimmune response in which retinal antigen specific T cells traffic
to the eye and produce inflammation in the retina
28. In this model,
TLR-4 signals are present at the site of immunisation, but not in the
target organ.
When EIU was induced, WT and TSP-1 KO mice both developed
ananterioruveitis, andthe infiltrating cellpopulation inbothmouse
strains was dominated in the early phase by neutrophils (Ly6G
1
cells), which do not express TSP-1 (data not shown). The other cell
populations present in the early phase, 12 hours following LPS
administration included both macrophages (CD11b
1 Ly6G
-) and T
cells (CD3e
1). The CD45
1 infiltrating cells were examined by flow
cytometry to establish into which population TSP-1 production seg-
regated, and we found that it localised to the non-CD3e
1 compart-
ment in wild type mice with approximately equal numbers of
infiltrating cells in either model (Fig 7A & B). Analysis of the
CD11b
1 Ly6G
- cellular fraction expressing TSP-1, revealed that for
the first 36 hours greater than 30% of these cells were producing
TSP-1, but by 60 hours this proportion had fallen by two thirds
(Fig 7C). Over the same period there was a reciprocal increase in
the fraction of CD3
1 T cells present (Fig 7D).
When EAU was induced in WT and TSP-1 KO mice, clinical
disease developed a little more rapidly in the TSP-1 KO animals
compared with WT controls, but followed similar kinetics and
reached a similar maximum disease score (Fig 8A). We analysed
CD11b
1 TSP-1 production (Fig. 8B) which is much lower than seen
at early time points in EIU. T cell cytokine production tested at day
26 was similar in PMA/Ionomycin stimulated from T cells obtained
frombothWTandTSP-1KOanimalsandincludedabout12%IFNc
positive cells (Fig. 8C). The low level of TSP-1 (Fig 8B) expression
was comparable to that we detected in the EIU model following the
maximum influx of CD3e
1 T cells at 60 hours and also the back-
ground levels of production that we have shown in vitro. Therefore
we conclude that in acute inflammation, TSP-1 can be produced by
inflammatory macrophages in vivo in response to LPS, but that this
synthesis is relatively short lived and sub-ordinate to regulation that
is associated with the local accumulation of Th1 lymphocytes.
Discussion
Macrophages thathave been exposed to a variety ofpro-inflammatory
stimuli are known as a source of induced TSP-1
20.I nt h i sp a p e rw e
have elucidated the mechanisms by which the level of TSP-1 protein
p r o d u c t i o ni sr e g u l a t e d ,a n ds h o w nt h a ti na na c u t ei n f l a m m a t o r y
environment, this production is inversely correlated with the accu-
mulation of CD3
1 T cells. Our results demonstrate that BM-MW can
integrate a number of different environmental cues to establish a
threshold for TSP-1 production, which is revealed should they also
encounter a TLR4 mediated signal. Th1 and Th2 cytokines raise the
threshold for TSP-1 production, and inhibit ongoing protein syn-
thesis, even from cells that have already encountered LPS (Fig. 2).
Importantly, and in contrast with Th1 and Th2 environments, in
the presence of IL-17 alone, macrophages can continue to produce
TSP-1. Since one function of TSP-1 is the activation of TGFb1, a
cytokine known to play a role in Th17 cell differentiation
33 continued
TSP-1 secretion and/or the presence of TSP-1 closely associated with
the differentiating T cell may favour Th17 cell development.
However, other signals can lower the threshold for TSP-1 secretion,
and this indicates that different populations of macrophages can
respond to the same TLR4 stimulus with altered levels of TSP-1 pro-
duction, defined as either the frequency or amount of protein (Fig. 4).
Differences in local cues are present in the healthy normal envir-
onment, as shown by the different responses of BM-MW versus P-
MW. This threshold is not directly regulated by the local concentration
of TSP-1 (Fig. 3), which means that the TSP-1 response by macro-
phages is independent of local TSP-1 accumulation. TSP-1 has a rela-
tively long half-life (540 minutes when measured in the circulation
34),
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Figure 4 | Peritoneal macrophages produce a soluble mediator that increases TSP-1 expression. BM-MW or Peritoneal MWs (P-MW) were cultured in
mediaaloneorstimulatedwithLPS.(A)P-MWproducedgreateramountsofTSP-1asindicatedbyincreasedTSP-11percentage(B)TSP-1proteinlevels
werehigherinP-MW.(C)About28%ofWTBM-MW,co-culturedwithTSP-1KOBM-MW(ratio1:1)producedTSP-1.Thisincreasedto48%whenWT
BM-MW were co-cultured with TSP-1 KOP-MW.
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the inflammatory microenvironment over relatively long periods of
time, comparedwithshort acting effectsofpro-inflammatorycytokines
such as TNF-a.
The signals that lower the threshold for TSP-1 production (e.g.
LPS plus PGE2) are the same as those often associated with the
generation of regulatory macrophages
26. Macrophages derived from
the peritoneal cavity, which have blunted nitric oxide responses
to LPS stimulation, produce elevated amounts of TSP-1 (Fig. 4).
Furthermore, in a corneal transplantation model the absence of
TSP-1 potentiated graft rejection
35. This presents a consistent pic-
ture,indicatingthatTSP-1isinducedincircumstanceswhereitplays
ananti-inflammatory role.However thisinterpretation cannotcom-
pletely explain findings in some autoimmune disease models.
OrganspecificautoimmunediseaseistheproductofaCD4
1Tcell
immune response, directed at self-proteins within the target organ
and recruiting a complex mixture of leukocytes
28. Many targeted
mutationsmodifytheexpressionofdiseaseandtheseeffectsareoften
consistent across a number of different models, for example IFN-c
knockout mice develop more severe EAE and EAU
36,37. The TSP-1
knockout mouse is an exception to this, as it is resistant to experi-
mental autoimmune encephalomyelitis (EAE) but susceptible to
experimental autoimmune uveoretinitis (EAU)
5,6. Since we have
shown that IL-17, but not IFNc or IL-4, is permissive for the con-
tinuedproductionofTSP-1,weproposethatthisallowsTh17cellsto
maintain a microenvironment that favours their differentiation.
These cells would in turn limit the expansion of Th1 cells. This
hypothesis is supported by the finding that in the corneal trans-
plantation model discussed above, there is an expansion of Th1 cells
associated with the TSP-1 knockout phenotype. The ability of Th17
cells to solicit TSP-1 from antigen presenting cells may be critical in
the early expansion of this cell population, especially in the EAE
model when it is induced under sub-optimal conditions. The critical
importance of Th17 cells in the development of EAE has been high-
lightedinrecentstudiesofIL-17reportermice
38,whileforEAUboth
Th1 and Th17 cell populations can induce disease independently of
the presence of the reciprocal cytokine
14,39. Therefore EAE in the
C57BL/6 model may be a more Th17 dependent disease than EAU
in the same strain.
The interaction between lymphocytes and macrophages in the
regulation of TSP-1 production is clearly seen in another model of
inflammationinvivo,inwhichLPSisusedtoinduceamodelofacute
uveitis. Here, there is an inverse correlation between the production
of TSP-1 and the accumulation of CD3
1 T cells (Fig 7). Because this
occurs relatively quickly, it likely reflects an active process rather
than the exhaustion of the macrophages. Taking our data together
with other studies
6,35 we conclude that the major effects of TSP-1 in
acuteinflammationoccurearlyandinresponsetoinnatestimulithat
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Figure 5 | LPS in combination with adenosine or PGE2 increase TSP-1
expression. (A)BM-MWswereculturedinmediaaloneorstimulatedwith
adenosine or CGS (a selective A2A agonist) alone or in combination with
LPS.Adenosine andCGS alonedid not up-regulate TSP-1expression. The
addition of Adenosine to LPS-stimulated cultures increased TSP-1
expression by about 1.5 fold, while the addition of CGS to LPS-stimulated
cultureincreasedTSP-1expression2fold.(B)WTandIL-10KOBM-MWs
were cultured in media alone or stimulated with LPS or LPS & PGE2 for
48 hrs. The addition of PGE2 increased TSP-1 expression 2-fold. (C) WT
andTNFR1KOBM-MWswereculturedinmediaaloneorstimulatedwith
LPS for 48 hrs. The TSP-1 response is independent of the presence of
TNFR1. Results are the averages for two independent experiments.
*p5,0.05Mann-WhitneyUtest.(D)WTBM-MWswerestimulatedwith
LPS 1 CGS for 24 hrs followed by the addition of IFN-c, IL-4, IL-17, or
IFN-c & IL-17 for a further 24 hrs. IFN-c and IL-4 reduced TSP-1
expression by 30-50%. IL-17 had no effect. Results are the averages from
two independent experiments. *p5,0.05 Mann-Whitney U test.
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SCIENTIFIC REPORTS | 2 : 512 | DOI: 10.1038/srep00512 5Figure 6 | TSP-1productionandretinalarchitectureinTSP-1KOanimals. (A)RNAwasextractedfrombone-marrowderivedmacrophagesfromWT
mice stimulated as shown. (B) OT-II CD4
1 T cells isolated from WT splenocytes were co-cultured with WT or TSP-1 KO KO macrophages, stimulated
with peptide and/or LPS. TSP-1 mRNA is expressed by un-activated macrophages and is upregulated by LPS stimulation. IFN-c down-regulates TSP-1
mRNAexpression.Inco-cultureexperimentsTSP-1mRNAwasonlydetectablewhenWT(andnotTSP-1KO)macrophageswherepresent.Furthermore
TSP-1mRNAwasnotdetectablewiththeinclusionof WTTcells.Resultsarerepresentativeof.3independentexperiments.(B)Th1andTh17cellswere
generated from OT-II CD41 T cells cultured in Th1- or Th17-polarising conditions. Th1 and Th17 cells were stimulated with aCD3/28 or PMA 1
Ionomycin. Neither naı ¨ve nor Th1 or Th17 differentiated T cells produced detectable TSP-1, despite the Th1 and Th17 cells producing significant
amounts of their signature cytokines (Th15 ,40% IFN-c1, Th175 ,60% IL-171) upon stimulation. LPS-stimulated TSP-1 null and WT BM-MWs
werestainedasapositive control (datanotshown).(C) Dendritic cellswere preparedfromWTorTSP-1 KOmiceby cultureinGM-CSF andsomewere
matured by the inclusion of LPS (1 mg/ml) for 18–20 hours. TSP-1 production in response to LPS was assessed in WT cells in comparison to TSP-1 KO
DCs and BM-MWs. Data is representative of 2 independent experiments. (D) The retinal thickness in 24-month-old TSP-1 KO mice was compared to
theiragedmatchedgeneticbackgroundcontrolanimals.Theaverageretinalthicknessattheregion500mmfromtheopticdiscmarginis199.0620.3mmin
WT mice (n510) and 168.7619.1mm in TSP-1 KO mice (n59, **p,0.002, Students-T test). The thickness includes the retinal ganglia cell layer to the
outer nuclear layer. The photoreceptor layer was excluded to avoid artefact.
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associated with the induction of Th1 and/or Th2 cytokines, infiltrat-
ing macrophages will no longer synthesise TSP-1, even with contin-
ued TLR4 ligation. Only in a strongly Th17 biased environment will
TSP-1 be produced.
In chronic EAU the presence of TSP-1 plays a role in controlling
the development of angiogenesis. When the retina is examined in
animals four months after the induction of EAU, retinal neovascular
membranes can be detected. These are markedly increased in the
absence of TSP-1
18. Therefore conditioning of the macrophages to
produce TSP-1 is likely to be more significant late in the disease
process and acutely a deficit of macrophage TSP-1 production does
not lead to a loss of other functional outcome measures of macro-
phage conditioning, implying that TSP-1 expression per se does not
directlysignalaswitchinmacrophagephenotype.TSP-1production
by macrophages is therefore subject to both acute and chronic con-
ditioning that has a significant impact on the outcome of organ
specific autoimmunity.
Methods
Animals. C57BL/6 mice were obtained from Harlan UK Limited (Oxford, UK), and
thrombospondin-1 deficient (TSP-1 KO) mice (C57BL/6 background) mice were
originally from Jack Lawler
14 and maintained in our facility at BC10. Toll-like
receptor4deficient (TLR4KO) mice(C57BL/6 background) wereoriginallyobtained
from the Research Institute for Microbial Diseases, Osaka University (Osaka, Japan),
and generously donated by Dr. Clare Bryant (University of Cambridge, Cambridge,
UK). B10.PL wild-type and IL-10KO mice were a kind gift of Prof. David C. Wraith
(Cellular & Molecular Medicine, University of Bristol, UK). All breeding colonies
were established within the Animal Service Unit at Bristol University (Bristol, UK).
Animals were housed in specific pathogen free conditions. Experiments were carried
out in compliance with University of Bristol institutional guidelines and under the
authority of a project licence from the UK Home Office.
Generation of Bone Marrow Derived Macrophages and Dendritic cells. Bone
marrow cells were isolated from the femurs and tibia of mice by flushing with
Dulbecco’s modified Eagle medium (DMEM). Single-cell suspensions were cultured
for 8 days in hydrophobic Teflon bags (supplied by Dr. M. Munder, University of
Heidelberg, Heidelberg, Germany
40) with DMEM containing 10% heat-inactivated
foetal calf serum (FCS), 5% normal horse serum, 1 mM sodium pyruvate, 2 mM L-
glutamine, 100 U/ml penicillin-streptomycin (all obtained from PAA Laboratories,
Somerset, UK), 50 mM 2-mercaptoethanol (Invitrogen, Paisley, UK) and 50 pg/ml
macrophage-colony stimulating factor (M-CSF) generated from L929 fibroblast-
conditioned media. Bone marrow-derived macrophages (BM-MWs) were then
harvested and washed in DMEM prior to plating. Greater than 95% of cells were
positive for the macrophage markers F4/80 and CD11b.
Monocyte-derived Dendritic Cells were prepared from bone marrow cells. To
depletemacrophages,thecellswerecentrifugedat500 gfor10minutes,re-suspended
in 20 ml complete media with GM-CSF and then transferred into tissue culture flask
(Corning,NY,USA)through40mmcellstrainer(BDBiosciences,Oxford,UK)before
cultured in a 5% vol./vol. CO2incubatorat 37uC for 2 hours. Adherent cells were left
in the flask whereas non-adherent cells were removed and centrifuged at 500 g for 5
minutes. Cells were then re-suspended in GM-CSF medium (4 ng/ml) and plated in
6-well tissue culture plates (Corning). Each well contained 2x10
6 cells per 5 ml GM-
CSFmedium.Theplateswerethenincubatedina5%vol./vol.CO2incubatorat37uC
and 2 ml of the media was changed with fresh GM-CSF medium on days 3, 6 and 8.
Onday9,1mg/mlofLPS(fromE.coli026:B6(Sigma-Aldrich,Dorset,UK)wasadded
to some wells in order to generate matured DCs and left for 18–20 hours in the 5%
vol./vol. CO2 incubator. On day 10, cells were harvested and washed with DMEM.
Isolation of Resident Peritoneal Macrophages. Mice were sacrificed and the
peritoneal cavity washed with 5 mls of ice-cold phosphate-buffered saline (PBS)
containing 5% FCS. The peritoneal cavity was gently agitated for 3 minutes before
retrievalofperitonealfluid.PeritonealcellswerewashedinDMEMandthenplatedin
DMEM containing 1% FCS, 1 mM sodium pyruvate, 2 mM L-glutamine and 100
U/ml penicillin-streptomycin for 2 hrs at 37uC. Non-adherent cells were removed
by gentle washing with media. Approximately 70% of adherent cells were positive for
the macrophage markers F4/80 and CD11b.
StimulationofMacrophages.BM-MWswereculturedataconcentrationof2x10
6/ml
in DMEM containing 1% FCS, 1 mM sodium pyruvate, 2 mM L-glutamine and
100 U/ml penicillin-streptomycin. Resident peritoneal macrophages (P-MWs) were
cultured at a concentration of 2.6x10
6/ml in DMEM containing 1% FCS, 1 mM
sodium pyruvate, 2 mM L-glutamine and 100 U/ml penicillin-streptomycin. In co-
cultureexperiments,wild-typeBM-MWswereculturedwithTSP-1KOP-MWsorthe
equivalentnumberofTSP-1KOBM-MWsascontrols.BothBM-MWandP-MWwere
plated 2 hours prior to stimulation, ensuring that both populations were activated
simultaneously. LPS or combinations of LPS and adenosine, the adenosine receptor
*
*
*
Figure 7 | TSP-1 expression during acute inflammation segregates to the
macrophage population and is reduced in the presence of activated T
cells. AnimalswithEndotoxin-Induced Uveitisweresacrificedatdifferent
time points after disease induction. Cells released from the eyes were
analysed by flow cytometry. (A) TSP-1 expression in macrophages
(CD45
1, CD11b
1, 1A8(Ly6G)
- cells) at 12 hours after treatment.
(B) CD45
1 cell infiltrate was detectable throughout the course of the
experiment and peaked at 36 hours. WT and TSP
KO animals had similar
levels of infiltrate (C) The level of TSP-1 production fell rapidly and
significantly over the first 60 hours of the disease course (D) The T cell
content of the infiltrate increased significantly with time to 60 hours after
the induction of disease. Results are representative of two individual
experiments, n5 $3 mice. *p5,0.05 Mann-Whitney U test.
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TSP-1 production. Cell suspensions of 500 ml were applied to 24-well flat bottom
culture plates and harvested after 24 or 48 hours of culture. LPS (100 ng/ml),
Adenosine (1mM), CGS21680 (1mM), IFN-c (100 U/ml), IL-17 (200 ng/ml) and
PGE2 (1 ng/ml) werepurchased fromSigma-Aldrich.IL-4(25 U/ml)waspurchased
from Peprotech.
Quantification of nitric oxide (NO) production. NO generation was measured in
culturesupernatantsafter24 hoursofcultureundervaryingexperimentalconditions.
NO was assayed by detection of the stable reaction product nitrite quantified using a
sodium nitrite standard in a Griess assay
27.
Staining of cells for analysis by flow cytometry. All staining protocols were
performedonice,instainingbuffer(PBScontaining1%FCSand0.1%sodiumazide).
Macrophages were harvested and pre-incubated with 24G2 cell supernatant for
10 minbeforeincubationwithprimarymAbat4uCfor20 min.Intracellularstaining
was carried out using a cytofix/cytoperm kit (BD Biosciences). For intracellular
staining, brefeldin A was added for the final 3 hours of cell culture. For TSP-1
staining, a biotinylated anti-TSP-1 mAb (Clone:D4.6; Thermoscientific, USA) was
added for 30 minutes, followed by a secondary streptavidin-fluorochrome conjugate
for30minutes.CellviabilitywasassessedusingLIVE/DEADfixabledeadcellstainkit
following the manufacturer’s protocol (Invitrogen, UK). TSP-1 staining was detected
intracytoplasmicallybutnotextracellularlywiththisprotocol(JBFandLBN,datanot
shown).AllmAbswerepurchasedfromBDBiosciencesunlessotherwisestated.Data
sets were acquired with a LSR II flow cytometer (BD Cytometry Systems), and
analysis carried out using FlowJo software (Tree Star, San Carlos, CA).
Isolation ofCD4
1 Tcells.Single-cellsuspensionswere prepared fromwhole spleens
and CD4
1 cells were isolated from splenocytes by negative selection using a MACS
separation kit (Miltenyi Biotec).
Generation of Th1 and Th17 cell lines. T cell lines were prepared using a protocol
adapted from Cox et al.
41. Briefly, CD41 T cells were purified from OT-II TCR
transgenic mice and activated with irradiated antigen presenting cells in RPMI
medium (10% FCS) in the presence of peptide (ovalbumin323–339, 10 mg/ml) and
eitheranti-IL-4(11B11),andIL-12(Th1cells)oranti-IFNc(XMG1.2)andIL-4(Th2
conditions), or anti-IL-4 plus anti- IFNc with human TGFb and IL-6. Cultures were
maintained with medium containing IL-2, and after one week re-stimulated with 2
mg/ml (Th1) or 10 mg/ml (Th2 and Th17) OVA peptide and IL-12 (Th1), IL-4 and
anti- IFNc (Th2) or TGFb, IL-6 and IL-23 with anti-IL-4 plus anti- IFNc.
Stimulation of CD4
1 T cells. CD41 T cells were cultured in flat-bottom 96-well
plates for 24 hours in DMEM containing 1% FCS, 1 mM sodium pyruvate, 2 mM L-
glutamineand100 U/mlpenicillin-streptomycin.StimulationwaswithPMA(50 ng/
ml) & ionomycin (25 ng/ml) (Sigma Aldrich) for the last 3 hours of culture or with
CD3/28-mediated in plates with a-CD3 Abs (10 mg/ml) and a-CD28 Abs (5 mg/ml)
(BD Pharmingen) in PBS under sterile conditions 24 hrs prior to use.
TSP-1 mRNA detection by RT-PCR. For TSP-1 message detection, RNA was
isolated from macrophages using Trizol reagent according to the manufacturers
instructions. cDNA was synthesised using the improm II Reverse transcription
system with random primers (Promega). TSP-1 message was detected using intron
spanningprimers,designedusingPrimer3andpurchasedfromSigma:TSP-Forward:
59-GCG TCC TTG TCC TTC ACT TC-39; TSP- Reverse: 59-TGC ACC TCC AAT
GAG TTC AA-39.
Induction of Endotoxin-induced Uveoretinitis (EIU) and Experimental
autoimmune uveoretinitis (EAU). Local administration of LPS was performed by
intravitreal injection in adult mice. Mice were anesthetized by i.p. injection of 150 ul
of Vetelar (ketamine hydrochloride 100 mg/ml; Pfizer, Sandwich, UK) and Rompun
(xylazine hydrochloride 20 mg/ml; Bayer, Newbury, UK) mixed with sterile water in
the ratio 0.6:1:84. The pupils of all animals weredilatedusing topical 1% tropicamide
and 2.5% phenylepherine (Chauvin Pharmaceuticals, Kingston-Upon-Thames,
Surrey, UK). Intravitreal injection of 100 ng LPSin 4 ul of PBS wasperformed under
directcontrolofasurgicalmicroscopewiththetipofa12 mm33-gauguehypodermic
needle.Theinjectionsitewastreatedoncewithchloramphenicolointment.Toinduce
EAU, mice were immunised subcutaneously with peptide (RBP-3-1-20
(GPTHLFQPSLVLDMAKVLLD) 500 mg) emulsified in complete Freud’s adjuvant
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Figure 8 | TSP-1 expression during acute inflammation experimental autoimmune uveoretinitis. (A) Clinical EAU assessed by TEFI was slightly
advanced compared to the WT control group. The peak of clinical disease ant the kinetics of disease in the first 30 days were similar. (B) Infiltrating
macrophages(CD11b
1cells)expressedlowlevelsofTSP-1atday26.(C)InfiltratingTcellsstimulatedwithPMA/Ionomycinproducedcomparablelevels
ofIFNcandIL-17at day26.Disease scores forWTandTSP-1KO miceup today32.n510per group.Cytokine measurements average ofcellsfrom7-8
individual eyes from two independent experiments.
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Biosciences).MicewerecoinjectedwithBordetellapertussistoxin(Sigma,Poole,UK)
intraperitoneally 1.5 mg per mouse.
Isolation of Ocular infiltrate. Infiltrating cells were isolated as previously
described
42. In brief, retina, ciliary body and choroid were removed and digested in
HBSS supplemented with 0.5 mg/ml collagenase D (Roche, Lewes, UK) and 750
U/ml DNase (Sigma) for 15 min at 37uC. After this time, any remaining tissue was
disrupted through a 70-mm cell strainer (BD Falcon), and the resulting single cell
suspension washed and resuspended in staining buffer.
Retinal thickness measurement. 24-month-old thrombospondin-1 knockout (TSP-
1 KO) mice and same age matched genetic background controls C57Bl/6J mice were
used. Eyecups were embedded in the optimal cutting temperature compound (OCT,
R. Lamb) and frozen in liquid nitrogen until used. Only sections including optic
nerveswereincludedandimagesofretinaweretakenat500mmdistancetoopticdisc
margin. Retinal thickness measurement (x3) was carried out in 40x images using
ImageJ software (NIH) from the inner edge of retinal ganglion cell layer to the outer
edge of the outer nuclear layer. To avoid the artifact of artificial retinal detachment,
the photoreceptor layer was excluded in this measurement.
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